Five Prime Therapeutics to Present at the Guggenheim Healthcare Talks Idea Forum
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 4, 2019--Five Prime Therapeutics, Inc. (NASDAQ:FPRX), a clinical-stage biotechnology company focused on discovering and developing…
